In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1857 News Items found
Mijin Kim seen working in laboratory.
Advice From a ‘Wunderkind’: Why MSK Is Great for Early Career Researchers

Learn why post-doctoral researcher Mijin Kim believes Memorial Sloan Kettering is an excellent choice for early career biomedical researchers, as she enjoys her recognition as a STAT Wunderkind, class of 2023.
Joanna Ihlo
Feature
Fighting Cancer on a Fixed Income: How MSK Helps Patients Cope With Financial Uncertainty

Learn how MSK helps patients navigate the intricacies of insurance and financial assistance throughout their cancer treatment.
Dr. Zsofia Stadler
Finding
Preventing Lynch Syndrome Cancers: New Study Suggests Immunotherapy Could Work

An analysis of patients with Lynch syndrome treated at MSK finds that immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming.
MSK physician Dr. Deb Schrag
Experimental Blood Test for Cancer Shows Potential To Screen for Multiple Types Simultaneously

Learn how a blood test could someday provide a way to detect cancers at an early stage.
Plastic and reconstructive surgeon Michelle Coriddi, MD
Q&A
Implant vs. Flap Breast Reconstruction Surgery: How To Decide

Memorial Sloan Kettering plastic and reconstructive surgeon Michelle Coriddi describes breast reconstruction options for women undergoing mastectomy, including implants, flap surgery, TRAM flap, and DIEP flap, and more.
Photo of Hispanic patient who had metaplastic breast cancer.
Expertise To Treat Metaplastic Breast Cancer From MSK’s Rare Breast Cancer Program

Patients like Michelle benefit from the specialized skills of experts in MSK’s Rare Breast Cancer Program.
Danielle Polumbo
Feature
How MSK Cares for People With Hereditary Breast Cancer: Danielle’s Story

Learn how Danielle has faced hereditary breast cancer caused by a BRCA1 gene mutation and had fewer side effects than traditional chemotherapy because of an experimental treatment at MSK.
Researchers Russell Kunes, Thomas Walle, and Dana Pe'er
MSK Researchers Develop New Open-Source Method To Improve Decoding of Single-Cell Data

MSK researchers have developed a new open-source computational method, dubbed Spectra, which improves the analysis of single-cell transcriptomic data — and made it freely available to researchers around the world.
Dr. Simon Powell
Feature
Advances From MSK Researchers Reported at 2023 ASTRO Meeting

Experts from MSK shared their work in more than 40 presentations and poster sessions at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology.
Close up of gloved hands working in a lab
MSK Research Highlights September 29, 2023

New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.